» Articles » PMID: 6469081

Optimal Dose of Oral Omeprazole for Maximal 24 Hour Decrease of Intragastric Acidity

Overview
Journal Gut
Specialty Gastroenterology
Date 1984 Sep 1
PMID 6469081
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

In a series of 59 experiments in nine duodenal ulcer patients, 24 hour intragastric acidity was measured before, during, and after treatment with daily oral omeprazole. Omeprazole 10, 20, and 30 mg/day for one week caused a 37, 90, and 97% decrease of 24 hour intragastric acidity, respectively. No further decrease of acidity was observed when the dose of omeprazole was doubled to 60 mg/day, or after a second week of treatment with 30 mg/day. One week after stopping treatment with omeprazole (14 doses) there was a significant 26% decrease of 24 hour intragastric acidity, with full recovery seven weeks later. Fasting plasma gastrin concentration was significantly raised during treatment with all doses of omeprazole. Omeprazole 30 mg/day is the optimal dose for a maximal decrease of 24 hour intragastric acidity in duodenal ulcer patients.

Citing Articles

The Impact of Sex on the Response to Proton Pump Inhibitor Treatment.

Helgadottir H, Bjornsson E Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139847 PMC: 10747337. DOI: 10.3390/ph16121722.


Problems Associated with Deprescribing of Proton Pump Inhibitors.

Helgadottir H, Bjornsson E Int J Mol Sci. 2019; 20(21).

PMID: 31684070 PMC: 6862638. DOI: 10.3390/ijms20215469.


On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug.

Lopez-Velazquez G, Fernandez-Lainez C, de la Mora-de la Mora J, Caudillo de la Portilla D, Reynoso-Robles R, Gonzalez-Maciel A Sci Rep. 2019; 9(1):8922.

PMID: 31222100 PMC: 6586891. DOI: 10.1038/s41598-019-45529-w.


Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Helgadottir H, Lund S, Gizurarson S, Metz D, Bjornsson E J Clin Gastroenterol. 2019; 54(3):227-234.

PMID: 30994520 PMC: 6800823. DOI: 10.1097/MCG.0000000000001200.


Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial).

Waghray A, Waghray N, Perzynski A, Votruba M, Wolfe M Dig Dis Sci. 2018; 64(1):158-166.

PMID: 30094626 DOI: 10.1007/s10620-018-5235-9.


References
1.
Pounder R, G Williams J, Misiewicz J . 24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet. 1975; 2(7944):1069-72. DOI: 10.1016/s0140-6736(75)90434-1. View

2.
Sharma B, Santana I, Walt R, Pounder R . Omeprazole and liver function tests. Lancet. 1983; 2(8345):346. DOI: 10.1016/s0140-6736(83)90327-6. View

3.
Richardson C, Walsh J, Hicks M . The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer. Gastroenterology. 1976; 71(1):19-23. View

4.
Sachs G, Chang H, Rabon E, SCHACKMAN R, Lewin M, Saccomani G . A nonelectrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem. 1976; 251(23):7690-8. View

5.
Pounder R, Hunt R, Vincent S, Misiewicz J . 24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut. 1977; 18(2):85-90. PMC: 1411296. DOI: 10.1136/gut.18.2.85. View